Hormone Health · Room to Lead

Menopause Hormone Therapy

For clients whose Room to Lead plan calls for it, I prescribe bioidentical Menopause Hormone Therapy (MHT) and desiccated thyroid — with a full risk-benefit conversation built into your care, not a prescription handed over on its own. Ontario residents only.

Dr. Erin Wiley, ND with a client
Doctor of Naturopathic Medicine Regulated by CONO Additional Prescribing Certification Ontario Residents Only
Root-Cause, Not a Prescription Alone

One tool within your Room to Lead plan.

Hormone therapy is one of the most effective, most requested tools I have for supporting the menopause transition — and it's something I want every client educated about, whether or not it ends up being right for them.

Inside Room to Lead, MHT isn't a standalone visit. It's considered as part of your Full Picture assessment and folded into your written plan, with a complete risk-benefit conversation so you can make an informed, confident choice — covered by the same ongoing visits and annual re-testing as the rest of your care.

The Evidence

Hormone Therapy Benefits

A full, honest look at where the evidence is strong and where it's still unclear — not a sales pitch.

Hot Flashes and Night Sweats

Vasomotor symptoms pose a significant risk to quality of life. This is the area that has by far the most evidence-based benefit for the use of MHT (Menopause Hormone Therapy).

Sleep Quality

If sleep is disturbed because of hot flashes and night sweats, MHT can have a significant benefit. In the absence of vasomotor symptoms, the evidence is unclear on the absolute benefit of MHT.

Mood Support

MHT can be an option for supporting mood changes during early perimenopause and is most effective when started earlier and taken for longer periods of time. Benefits are unclear when therapy is started postmenopause.

Cognition

MHT benefits those who have undergone surgical menopause at an earlier age. The evidence for support during the menopause transition is unclear.

Diabetes

Evidence suggests that those who start MHT have a 30% reduction in new-onset type 2 diabetes. However, MHT is not considered a treatment or prevention strategy for diabetes.

Bone Density and Fracture Risk

MHT has been shown to increase bone mineral density by 2–5%. Oral therapy can reduce the risk of fracture by up to 30% in those with osteopenia.

Colon Cancer

Those who took MHT had a 25% reduced incidence of colon cancer. MHT is not a prevention strategy for colon cancer.

All-Cause Mortality

Those who took MHT had a 30% reduced risk of death from all causes. This is not a life-extension strategy but a benefit found by correlation.

Dr. Erin Wiley, ND
Questions About Hormone Therapy?

The risks and benefits deserve a real conversation.

Whether hormone therapy has a place in your plan needs to be weighed carefully, in the context of a therapeutic relationship — not decided from a page. A discovery call is the place to start that conversation.

Book a Discovery Call
Go Deeper

Resources

Some of the best independent resources available for making an informed choice — I'm here to help you interpret them in the context of your own health.

NAMS — Position Statements

The North American Menopause Society develops position statements and reports on clinical issues pertinent to women at midlife and beyond.

SWAN — Fact Sheets

Major findings from the Study of Women's Health Across the Nation on bone health, memory and cognition, hot flashes, sleep, and more.

Women's Health Initiative

Research on risk factors, prevention, and early detection of serious health conditions, so postmenopausal women thrive.

Ready When You Are

Start with a discovery call.

A short conversation to understand your goals and see whether hormone therapy has a place in your Room to Lead plan.

Book Your Discovery Call